Name | Number of supported studies | Average coverage | |
---|---|---|---|
mast cell | 5 studies | 18% ± 3% | |
glutamatergic neuron | 5 studies | 21% ± 7% | |
placental villous trophoblast | 3 studies | 49% ± 13% | |
interneuron | 3 studies | 19% ± 1% |
Insufficient scRNA-seq data for expression of NFE2L3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 754.89 | 963 / 966 | 98% | 58.72 | 519 / 527 |
stomach | 100% | 811.20 | 358 / 359 | 98% | 52.13 | 281 / 286 |
pancreas | 100% | 916.35 | 328 / 328 | 94% | 22.12 | 167 / 178 |
lung | 100% | 1013.46 | 578 / 578 | 93% | 24.91 | 1071 / 1155 |
esophagus | 100% | 464.56 | 1441 / 1445 | 93% | 32.42 | 170 / 183 |
bladder | 100% | 460.52 | 21 / 21 | 88% | 31.57 | 441 / 504 |
uterus | 100% | 527.05 | 170 / 170 | 79% | 18.14 | 363 / 459 |
ovary | 98% | 413.39 | 177 / 180 | 80% | 11.77 | 344 / 430 |
breast | 100% | 825.00 | 459 / 459 | 77% | 14.83 | 865 / 1118 |
kidney | 100% | 990.70 | 89 / 89 | 77% | 14.43 | 697 / 901 |
thymus | 99% | 501.10 | 648 / 653 | 76% | 21.67 | 457 / 605 |
skin | 100% | 1187.34 | 1801 / 1809 | 71% | 16.86 | 334 / 472 |
prostate | 99% | 552.22 | 243 / 245 | 39% | 4.19 | 195 / 502 |
liver | 97% | 444.97 | 220 / 226 | 21% | 3.82 | 85 / 406 |
adrenal gland | 100% | 547.56 | 258 / 258 | 2% | 0.21 | 5 / 230 |
brain | 84% | 449.28 | 2226 / 2642 | 16% | 1.87 | 112 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.14 | 29 / 29 |
spleen | 100% | 1393.15 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.47 | 1 / 1 |
adipose | 100% | 768.39 | 1203 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 34.14 | 43 / 45 |
blood vessel | 95% | 336.04 | 1263 / 1335 | 0% | 0 | 0 / 0 |
heart | 90% | 250.36 | 778 / 861 | 0% | 0 | 0 / 0 |
muscle | 85% | 221.48 | 679 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 727.66 | 749 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.10 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0140467 | Biological process | integrated stress response signaling |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
Gene name | NFE2L3 |
Protein name | Nuclear factor (Erythroid-derived 2)-like 3 NFE2 like bZIP transcription factor 3 Nuclear factor erythroid 2-related factor 3 (NF-E2-related factor 3) (NFE2-related factor 3) (Nuclear factor, erythroid derived 2, like 3) |
Synonyms | NRF3 tcag7.225 |
Description | FUNCTION: Activates erythroid-specific, globin gene expression. |
Accessions | Q9Y4A8 ENST00000056233.4 ENST00000607375.1 A4D178 U3KQ19 |